Can-Fite BioPharma Ltd. Severance Costs
Can-Fite BioPharma Ltd. (CANF) reported Severance Costs of $53.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2026-03-26
| Period end | Severance Costs 12 month |
|---|---|
| 2025-12-31 | $53.00K 20-F · filed 2026-03-26 |
| 2024-12-31 | $49.00K 20-F · filed 2026-03-26 |
| 2023-12-31 | $47.00K 20-F · filed 2026-03-26 |
| 2022-12-31 | $51.00K 20-F · filed 2025-04-14 |
| 2021-12-31 | $53.00K 20-F · filed 2024-03-28 |
| 2020-12-31 | $46.00K 20-F · filed 2023-03-30 |
| 2019-12-31 | $42.00K 20-F · filed 2022-03-24 |
| 2018-12-31 | $42.00K 20-F · filed 2021-03-25 |